Intravascular hemolysis: A disease mechanism not to be ignored

Acta Haematologica

Volumn 132, Issue 1, 2014, Pages 97-99

  Conran, Nicola ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HEME; HEMOGLOBIN; NITRIC OXIDE; HEMOGLOBIN BETA CHAIN;

ANEMIA; BETA THALASSEMIA; DISEASE ASSOCIATION; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; INTRAVASCULAR HEMOLYSIS; LEG ULCER; LEUKOCYTE ADHERENCE; NONHUMAN; OXIDATIVE STRESS; PRIAPISM; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SICKLE CELL ANEMIA; SPLENECTOMY; THALASSEMIA INTERMEDIA; THROMBOCYTE ACTIVATION; BLOOD VESSEL OCCLUSION; CLINICAL FEATURE; HEREDITARY SPHEROCYTOSIS; INFLAMMATION; NOTE; PATHOPHYSIOLOGY; THROMBOCYTE COUNT; THROMBOPHILIA;

BETA-THALASSEMIA; FEMALE; HEMOGLOBIN E; HEMOLYSIS; HUMANS; MALE; SPLENECTOMY; THROMBOPHILIA;

EID: 84893692963     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000356836     Document Type: Review

References (10)

1. Olivieri NF, Weatherall DJ: Clinical aspects of beta thalassemia and related disorders; in Steinberg MH, Forget BG, Higgs DR, Weatherall DJ (eds): Disorders of Hemoglobin, ed 2. New York, Cambridge University Press, 2009, chapt 17, pp 357-416.
2. Rother RP, Bell L, Hillmen P, Gladwin MT: The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005; 293: 1653-1662.
3. Kato GJ, Gladwin MT, Steinberg MH: Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 2007; 21: 37-47.
4. Rodeghiero F, Ruggeri M: Short-and longterm risks of splenectomy for benign haematological disorders: should we revisit the indications? Br J Haematol 2012; 158: 16-29.
5. Atichartakarn V, Chuncharunee S, Archararit N, Udomsubpayakul U, Aryurachai K: Intravascular hemolysis, vascular endothelial cell activation, and thrombophilia in splenectomized patients with hemoglobin E/α-thalassemia disease. Acta Haematol 2014;132:100-107.
6. Westerman M, Pizzey A, Hirschman J, Cerino M, Weil-Weiner Y, Ramotar P, Eze A, Lawrie A, Purdy G, Mackie I, Porter J: Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy. Br J Haematol 2008; 142: 126-135.
7. Sakamoto TM, Canalli AA, Traina F, Franco-Penteado CF, Gambero S, Saad ST, Conran N, Costa FF: Altered red cell and platelet adhesion in hemolytic diseases: hereditary spherocytosis, paroxysmal nocturnal hemoglobinuria and sickle cell disease. Clin Biochem 2013, E-pub ahead of print.
8. Rabhi S, Benjelloune H, Meziane M, Amrani M, Berrady R, Mikou O, Mernissi FZ, Bono W: Hereditary spherocytosis with leg ulcers healing after splenectomy. South Med J 2011; 104: 150-152.
9. Crary SE, Ramaciotti C, Buchanan GR: Prevalence of pulmonary hypertension in hereditary spherocytosis. Am J Hematol 2011; 86:E73-E76.
10. Djaldetti M, Bergman M, Salman H, Cohen AM, Fibach E, Bessler H: On the mechanism of post-splenectomy leukocytosis in mice. Eur J Clin Invest 2003; 33: 811-817.